Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Store-operated calcium entry regulator STIMATE (STIMATE, also known as TMEM110) is an endoplasmic reticulum-resident multi-transmembrane protein that regulates store-operated calcium entry (SOCE) by maintaining and remodeling ER-plasma membrane junctions crucial for calcium signaling. It acts as a positive modulator of SOCE by physically associating with stromal interaction molecule 1 (STIM1), promoting STIM1’s conformational switch to an activated state and facilitating the interaction with ORAI1 calcium channels on the plasma membrane. Depletion of STIMATE/TMEM110 impairs STIM1 relocalization, reduces Ca²⁺ influx, and suppresses downstream activation of the calcineurin/NFAT signaling pathway. This protein is not a classic therapeutic target (e.g., receptor, enzyme, or transporter) but is important for the physiological regulation of calcium signaling complexes at the ER–plasma membrane interface
N/A (No drugs target this molecule; mechanistically, TMEM110 (STIMATE) promotes STIM1 activation and aids the formation of Ca²⁺ influx complexes, but this is not related to known drug actions.)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Store-operated calcium entry regulator STIMATE (STIMATE).